Patents by Inventor David Hartley

David Hartley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TUBING HANGER RUNNING TOOL SYSTEM AND METHOD
    Publication number: 20150252635
    Abstract: A system including a tubing hanger running tool (THRT), including one or more stab connectors, and a planetary gear system, wherein the planetary gear system is configured to couple and uncouple the THRT from a first hydrocarbon extraction component.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 10, 2015
    Applicant: Cameron International Corporation
    Inventors: David Hartley, Alan Appleyard, Ted Thornburrow, Paul Hesketh
  • SYSTEM, METHOD, AND STORAGE MEDIUM FOR GENERATING HYPOTHESES IN DATA SETS
    Publication number: 20150235138
    Abstract: A method for generating hypotheses in a corpus of data comprises selecting a form of ontology; coding the corpus of data based on the form of the ontology; generating ontology space based on coding results and the ontology; transforming the ontology space into a hypothesis space by grouping hypotheses; weighing hypotheses included in the hypothesis space; and applying a science-based sorting algorithm configured to model a science-based treatment of the weighted hypotheses.
    Type: Application
    Filed: January 15, 2015
    Publication date: August 20, 2015
    Applicant: GEORGETOWN UNIVERSITY
    Inventors: Ophir Frieder, David Hartley
  • Endovascular stent graft with self-closing perfusion branch
    Patent number: 8906086
    Abstract: A prosthesis having a tubular body of a biocompatible graft material having a proximal end, a distal end, a lumen therethrough, and a sidewall. The prosthesis includes at least one perfusion branch extending from the sidewall of the tubular body and having a proximal end, a distal end, and a lumen therethrough, where the lumen of the perfusion branch is in temporary fluid communication with the lumen of the tubular body. The perfusion branch comprises a self-sealing component, that after predetermined period of time precludes fluid flow out of the distal end of the perfusion branch.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 9, 2014
    Assignee: Cook Medical Technologies LLC
    Inventors: Blayne Roeder, David Hartley
  • ENDOVASCULAR STENT GRAFT WITH SELF-CLOSING PERFUSION BRANCH
    Publication number: 20140277369
    Abstract: A prosthesis having a tubular body of a biocompatible graft material having a proximal end, a distal end, a lumen therethrough, and a sidewall. The prosthesis includes at least one perfusion branch extending from the sidewall of the tubular body and having a proximal end, a distal end, and a lumen therethrough, where the lumen of the perfusion branch is in temporary fluid communication with the lumen of the tubular body. The perfusion branch comprises a self-sealing component, that after predetermined period of time precludes fluid flow out of the distal end of the perfusion branch.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventors: Blayne A. Roeder, David Hartley
  • Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 8466179
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: June 18, 2013
    Assignee: EKR Therapeutics, Inc.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 8466178
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: June 18, 2013
    Assignee: EKR Therapeutics, Inc.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 8455524
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: June 4, 2013
    Assignee: EKR Therapeutics, Inc.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
    Publication number: 20110152327
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Application
    Filed: December 23, 2010
    Publication date: June 23, 2011
    Applicant: EKR THERAPEUTICS, INC.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
    Publication number: 20110086892
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Application
    Filed: December 17, 2010
    Publication date: April 14, 2011
    Applicant: EKR THERAPEUTICS, INC.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • PYRIMIDINE DERIVATIVES
    Publication number: 20100267755
    Abstract: The invention provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C1-2alkyl substituted by one to five fluorine atoms, C3-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl, C4-12bridged cycloalkyl, A(CR7R8)n and B(CR7R8)n; R3 is selected from the group consisting of C1-6alkyl, NH2 and R10CONH; R4 is C1-2alkyl substituted by one to five fluorine atoms; R5 is selected from the group consisting of H, C1-4alkyl, C1-2alkyl substituted with one to five fluorine atoms, halogen and C3-10cycloalkylC0-6alkyl, with the proviso that when R6 is H R5 is not H.
    Type: Application
    Filed: May 23, 2002
    Publication date: October 21, 2010
    Applicants: GLAXO GROUP LIMITED, Jennifer Margaret GREEN
    Inventors: Gianpaolo Bravi, Malcolm Clive Carter, Richard Howard Green, Jennifer Margaret Doughty, Charles David Hartley, Alan Naylor, Martin Pass, Jeremy John Payne, Neil Anthony Pegg
  • Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
    Publication number: 20100168186
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 1, 2010
    Applicant: EKR THERAPEUTICS, INC.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 7659290
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: February 9, 2010
    Assignee: EKR Therapeutics, Inc.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 7659291
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: February 9, 2010
    Assignee: EKR Therapeutics, Inc.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • 2-CARBOXY THIOPHENE DERIVATIVES AS ANTI VIRAL AGENTS
    Publication number: 20090274655
    Abstract: Anti-viral agents of compounds of Formula (I): wherein A, R1, R2 and R3 are as defined in the specification, processes for their preparation and their use in HCV treatment are provided.
    Type: Application
    Filed: November 15, 2007
    Publication date: November 5, 2009
    Inventors: Richard Martin Grimes, Charles David Hartley, Jacqueline Elizabeth Mordaunt, Pritom Shah, Martin John Slater, Gemma Victoria White
  • Pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 7612102
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: November 3, 2009
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • 4-(PYRAZINE-2-YL) -PYRROLIDINE -2-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF AS HEPATITIS C VIRUS INHIBITORS
    Publication number: 20090227600
    Abstract: Anti-viral agents of Formula (Ia) wherein: A represents hydroxy; B represents C(O)R3 wherein R3 is 4-tert-butyl-3-methoxyphenyl; D represents 1,3-thiazol-2-yl or 5-methyl-1,3-thiazol-2-yl; E represents pyrazin-2-yl; G represents 1,3-thiazol-2-ylmethyl, 1,3-thiazol-4-ylmethyl, 1,2-thiazol-3-ylmethyl, or 1H-pyrazol-1-ylmethyl; and salts, solvates and esters thereof; provided that when A is esterified to form —OR where R is selected from straight or branched chain alkyl, aralkyl, aryloxyalkyl, or aryl, then R is other than tert-butyl, processes for their preparation and their use in HCV treatment are provided.
    Type: Application
    Filed: October 24, 2005
    Publication date: September 10, 2009
    Inventors: Rossella Guidetti, David Haigh, Charles David Hartley, Peter David Howes, Fabrizio Nerozzi, Stephen Allan Smith
  • Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
    Publication number: 20090182018
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Application
    Filed: March 19, 2009
    Publication date: July 16, 2009
    Applicant: EKR THERAPEUTICS, INC.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
    Publication number: 20090182017
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Application
    Filed: March 19, 2009
    Publication date: July 16, 2009
    Applicant: EKR THERAPEUTICS, INC.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Stephens, Camellia Zamiri
  • Antiviral 2-Carboxy-Thiophene Compounds
    Publication number: 20090136448
    Abstract: Anti-viral agents of compounds of Formula (I): wherein A, R1, R2 and R3 are as defined in the specification, processes for their preparation and their use in HCV treatment are provided.
    Type: Application
    Filed: December 20, 2006
    Publication date: May 28, 2009
    Inventors: John Andrew Corfield, Richard Martin Grimes, David Harrison, Charles David Hartley, Peter David Howes, Joelle Le, Malcolm Lees Meeson, Jacqueline Elizabeth Mordaunt, Pritom Shah, Martin John Slater, Gemma Victoria White
  • Package
    Patent number: D643745
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: August 23, 2011
    Assignee: My Goodness Limited
    Inventor: David Hartley